Search

everythinglearnresearchcommunity

for

Search:↓

RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

D-004 shows moderate antidepressant effects but is less effective than Sertraline and Imipramine.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

RU58841, an androgen receptor blocker, significantly increased hair density, thickness, and length in monkeys when applied topically daily for several months.

Methylation in specific gene region causes finasteride resistance in some BPH patients.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Antisense oligonucleotides can reduce androgen receptor levels in skin cells, suggesting potential for treating skin disorders.

The treatment effectively promotes hair regrowth in androgenetic alopecia without causing skin irritation.

4-(4-Phenoxybenzoyl)benzoic acid derivatives can both increase and decrease certain types of reactive oxygen species, and may be relevant to hair loss.

Certain Dibenzo derivatives may help treat prostate cancer.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

PM-9, like finasteride, may help treat certain diseases by blocking a key enzyme.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

Girard's reagent P improves detection of spironolactone and its metabolites.

Methylation of the 5-AR2 gene may cause resistance to Finasteride in BPH patients.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

PRGF treatment safely and effectively helps hair loss.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Neurosteroids help control dopamine responses in the brain.